Normal view MARC view ISBD view

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary

Wizemann, Theresa M

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies - Washington, DC National Academies Press 2009 - xviii, 131 p. : ill. ; 23 cm

Includes bibliographical references (p. 104-105)

ISBN: 9780309120883

ISSN: 2010478547

Subjects--Topical Terms:
Drugs - Design
Models, Economic - United States
Orphan Drug Production - economics - United States
Orphan drugs - Government policy - United States
Pharmaceutical policy - United States
Research - economics - United States

Dewey Class. No.: 615.19 WIZ

Print
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary

Find us on the map